Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis in 2008.

Lawrence S Chan1

  • 1University of Illinois College of Medicine, Chicago, IL 60612, USA. larrycha@uic.edu

Current Directions in Autoimmunity
|May 8, 2008
PubMed
Summary
This summary is machine-generated.

Atopic dermatitis, a chronic inflammatory skin condition, is increasingly prevalent globally. Research links epidermal barrier defects, like filaggrin mutations, to heightened immune responses and disease development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 vaccination-linked granuloma annulare in two patients.

Skin health and disease·2024
Same author

Venous hemangioma arising within the nailbed: A rare clinical presentation.

JAAD case reports·2024
Same author

Disparities of Cutaneous Malignancies in the US Military.

Cutis·2022
Same author

Diacerein Alone and in Combination with Infliximab Suppresses the Combined Proinflammatory Effects of IL-17A, IL-22, Oncostatin M, IL-1A, and TNF-alpha in Keratinocytes: A Potential Therapeutic Option in Psoriasis.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2021
Same author

Solving the VA Physician Shortage Problem: The Right Thing to Do.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2019
Same author

IL-4 dysregulates microRNAs involved in inflammation, angiogenesis and apoptosis in epidermal keratinocytes.

Microbiology and immunology·2018
Same journal

The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.

Current directions in autoimmunity·2010
Same journal

TNF in host resistance to tuberculosis infection.

Current directions in autoimmunity·2010
Same journal

TNF-alpha and obesity.

Current directions in autoimmunity·2010
Same journal

TNF and bone.

Current directions in autoimmunity·2010
Same journal

TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.

Current directions in autoimmunity·2010
Same journal

T cells as sources and targets of TNF: implications for immunity and autoimmunity.

Current directions in autoimmunity·2010
See all related articles

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Atopic dermatitis (eczema) is a chronic, itchy, inflammatory skin disease with increasing global prevalence.
  • While not classically autoimmune, autoantigens are identified, and the disease involves cytokines, chemokines, T cells, and inflammatory cells.
  • Evidence suggests skin barrier defects and angiogenesis play roles in atopic dermatitis pathogenesis.

Purpose of the Study:

  • To review the current understanding of atopic dermatitis pathogenesis, including genetic and immunological factors.
  • To discuss the link between epidermal barrier defects, such as filaggrin mutations, and immune system overactivity.
  • To explore recent advancements in atopic dermatitis management and the 'intrinsic' vs. 'extrinsic' classification debate.

Main Methods:

Related Experiment Videos

  • Review of existing literature on atopic dermatitis.
  • Analysis of genetic studies, particularly those involving filaggrin (FLG) mutations.
  • Synthesis of immunological findings related to cytokines, chemokines, and cellular players.
  • Discussion of clinical observations and emerging management strategies.

Main Results:

  • Mutations in the filaggrin gene (FLG) are strongly associated with atopic dermatitis, affecting skin barrier function.
  • A significant percentage of individuals with FLG null alleles develop atopic dermatitis, highlighting the barrier defect-immune response link.
  • The disease involves a complex interplay of inflammatory cells and mediators, alongside compromised skin barrier integrity.

Conclusions:

  • Epidermal barrier dysfunction, particularly due to filaggrin mutations, is a key factor in atopic dermatitis development.
  • Atopic dermatitis pathogenesis involves a complex immune response triggered by environmental factors penetrating a weakened skin barrier.
  • Ongoing research and new management strategies aim to address the multifaceted nature of this prevalent skin condition.